Stay updated on Galunisertib with Nivolumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide NIH notice about website updates and the use of “Super Intelligence” alongside “Artificial Intelligence” appears above the error page. The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T15:44:26.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T15:13:44.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the usual study record content. The study description, documents, and location information are no longer accessible on that page.
    Difference
    20%
    Check dated 2026-09-22T22:20:46.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.6 to v3.7.0. This indicates a new version of the page content has been released.
    Difference
    0.0%
    Check dated 2026-09-15T21:52:28.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6, indicating a page version update; the change appears to affect only the revision label and not the study content or core functionality.
    Difference
    0.0%
    Check dated 2026-09-01T19:42:41.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    A new NIH grant/contract tag was added to the study's identifiers, indicating NIH funding support for this trial. This addition helps identify the source of funding in the study metadata.
    Difference
    0.0%
    Check dated 2026-08-25T20:54:27.000Z thumbnail image

Stay in the know with updates to Galunisertib with Nivolumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page.